Disposition kinetics, bioavailability and renal clearance of cefepime in calves

Veterinary Research Communications

Volumn 29, Issue 1, 2005, Pages 69-79

  Ismail, M M ^a  

^a Cairo University   (Egypt)

Author keywords

Bioavailability; Calves; Cefepime; Pharmacokinetics; Urine

Indexed keywords

CEFEPIME;

ANIMAL EXPERIMENT; ARTICLE; CATTLE; COMPARTMENT MODEL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; IN VITRO STUDY; KIDNEY CLEARANCE; NONHUMAN; STEADY STATE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CATTLE; CEPHALOSPORINS; CREATININE; CROSS-OVER STUDIES; FEMALE; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; TISSUE DISTRIBUTION;

FRIESIA;

EID: 8144228306     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:VERC.0000046738.52788.3c     Document Type: Article

References (40)

1. Baggot, J.D., 1977. Some aspects of clinical pharmacokinetics in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 1, 5-18
2. Balant, L., Dayer, P. and Auckenthaler, R., 1985. Clinical pharmacokinetics of the third generation cephalosporins. Clinical Pharmacokinetics, 10, 101-143
3. Barbhaiya, R.H., Knupp, C.A., Tenney, J., Martin, R.P., Weidler, D.J. and Pittman, K.A., 1990. Safety, tolerance and pharmacokinetics of cefepime administered intramuscularly to healthy subjects. Journal of Clinical Pharmacology, 30, 900-910
4. Barbhaiya, R.H., Knupp, C.A., Forgue, S.T., Matzke, G.R., Halstenson, C.E., Opsahl, J.A., and Pittman, K.A., 1991. Disposition of the cephalosporin cefepime in normal and renally impaired subjects. Drug Metabolism and Disposition, 19, 68-73
5. Barbhaiya R.H., Forgue, S.T., Gleason, C.R., Knupp, C.A., Pittman, K.A, Weidler, D.J., Movahhed, H., Tenney, J. and Martin, R.P., 1992. Pharamacokinetics of cefepime after single and multiple intravenous administration in healthy subjects. Antimicrobial Agents and Chemotherapy, 36, 552-557
6. Bastianello, S.S. and Jonker, M.R., 1981. A report on the occurrence of septicaemia caused by Pasteurella multocida type E in cattle from southern Africa. Journal of the South African Veterinary Association 52, 99-104
7. Bennet, J.V., Brodie, J.L., Benner, E.J. and Kirby, W.M.M., 1966. Simplified accurate method for antibiotic assay of clinical specimens. Appllied Microbiology, 14, 170-177
8. Butler, D.G. and Clarke, C.R., 1994. Diarrhoea and dysentery in calves. In: C.L. Gyles (ed.), Escherichia coli in Domestic Animals and Human, (CAB International, Wallingford, UK), 91-116
9. Carrelts, J.C. and Wagner, D.J., 1999. The pharmacokinetics, safety and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion. Annal Pharmacotherapy, 33, 1258-1261
10. Contrepois, M., Dubourguier, H.C., Parodi, A.L., Girardeau, J.P. and Dllier, J.L., 1986. Septicaemic Escherichia coli and experimental infection of calves. Veterinary Microbiology, 12, 109-118
11. Craig, A.W. and Suh, B. 1980. Methods for determination of protein binding. In: V. Lorian (ed), Antibiotics in Laboratory Medicine, (Williams and Wilkins, Baltimore, London), 265-297
12. Craig, W.A., 1995. Interrelathionship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad spectrum cephalosporins. Diagnostic Microbiology of Infectious Disease, 22, 89-96
13. Cunha, B.A. and Gill, M.V., 1995. Cefepime. Medical Clinics of North America, 79, 721-732
14. Forgue, S.T., Shyu, W.C., Gleason, C.R., Pittman, K.A., and Barbhaiya, R.H., 1987. Pharmacokinetic of the novel cephalosporin cefepime (BMY-28142) in rats and monkeys. Antimicrobial Agents and Chemotherapy 31, 799-804
15. Fuchs, P.C., Jones R.N., Barry, A.L. and Thornsberry, C., 1985. Evaluation of the in vitro activity of BMY-28142, a new broad spectrum cephalosporin. Antimicrobial Agents and Chemotherapy, 27, 679-682
16. Gardner, S.Y. and Papich, M.G., 2001. Comparison of cefepime pharmacokinetic in neonatal foals and adult dogs. Journal of Veterinary Pharmacology and Therapeutics, 24, 187-192
17. Gibaldi, M. and Perrier, D., 1982. Non-compartmental analysis based on statistical moment theory. In: Pharmacokinetics, 2nd edn, (Marcel Dekker, New York), 409-424
18. Guglick, M.A., MacAllister, C.G., Clarke, C.R., Pollet, R., Hague, C. and Clarke J.M., 1998. Pharmacokinetics of cefepime and comparison with those of ceftiofur in horses. American Journal of Veterinary Research 59, 458-463
19. Hamelin B.A., Moore, N., Knupp, C.A., Ruel, M., Vall, F. and Lebel, M., 1993. Cefepime pharmacokinetics in cystic fibrosis. Pharmacotherapy 13, 465-470
20. Kalman, D., Barriere, S.L. and Johnson, B.L., 1992. Pharmacokinetics disposition and bactericidal activities of cefepime, ceftazidime and cefoperazone in serum and blister fluid. Antimicrobial Agents and Chemotherapy, 36, 453-457
21. Kessler, R.E., Bies, M., Buck, R.E., Chisholm, D.R., Pursiano, T.A., Tsai, Y.H., Misiek, M., Price, K.E. and Leitner, F., 1985. Comparison of a new cephalosporin, BMY-28142 with other broad spectrum β-lactam antibiotics. Chemotherapy, 27: 207-216
22. Kieft, H., Hoepelman, A.I., Knupp, C.A., Van Dijk A., Branger, J.M., Struyven, B.A. and Verhoef, J.L., 1993. Pharmacokinetics of cefepime in patients with sepsis syndrome. Antimicrobial Agents and Chemotherapy 32, 117-122
23. Kovarik, J.M., Maaten, J.C., Rademaker, C.M., Deenstra, M., Hoepelman, I.M., Hart, H.C., Matzke, G. and Verhoef, J., 1990. Pharmacokinetics of cefepime in patients with respiratory tract infections. Antimicrobial Agents and Chemotherapy, 34, 1885-1888
24. Mevius, D.J. and Hartman, E.G., 2000. In vitro activity of 12 antibiotics used in veterinary medicine against Mannheimia haemolytica and Pasteurella multocida isolated from calves in Netherlands. Tijdschrift voor Diergeneeskunde, 125, 147-152
25. Michael, D.R., Yamashita, T. S., Knupp, C.K., Veazey, J.M, and Blumer, J.L., 1997. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children. Antimicrobial Agents and Chemotherapy, 10, 1783-1787
26. Nakanomyo, H., Esumi, Y., Takaichi, M., Seki, H., Ninomiya, S., Okamura Y. and Sudo, Y., 1992. Study on the pharmacokinetics of cefepime (II). Japanease Journal of Antibiotic, 24, 938-942
27. Neu, H.C., 1985. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. American Journal of Medicine 79(Supplement 2A), 2-13
28. Ogtrop, M.L., Mattie, H., Guiot, H.F., Strijen, E., Hazekamp, A.M. and Furth, R., 1990. Comparative study of the effects of four cephalosprins against Escherichia coli in vitro and in vivo. Antimicrobial Agents and Chemotherapy, 34, 1932-1937
29. Orden, J.A., Ruiz S.Q., Garcia, J.A., Cid, S.D. and Dela F.R., 2000. In vitro susceptibility of Escherichia coli strains isolated from diarrhetic dairy calves to 15 antimicrobial agents. Journal of Veterinary Medicine B, 47, 329-335
30. Osbaldiston, G.W, 1971. Kidney function. In: J.J. Kanko and C.E. Cornelitus (eds), Clinical Biochemistry of Domestic Animals, 2nd edn, (Academic Press, New York), 304
31. Pechere, J.C., Wilson, W. and Neu, H.C., 1995. Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins. Journal of Antimicrobial Chemotherapy, 20, 383-387
32. Sanders, C.C. and Sanders, W.E., 1992. Beta-lactam resistance in Gram-negative bacteria: Global trends and clinical impact. Clinical Infectious Disease, 15, 824-839
33. Siest, G., Henny, J., Schiele, F. and Young, D.S., 1985. Colorimetric determination of creatinine. In: Siest, G., Henny, J., Schiele, F. and Young, D.S., editors. Interpretation of Clinical Laboratory Tests 3rd edn, (Biomedical Publications, Foster City, CA)
34. Snedecor, G.W. and Cochran, T., 1976. Statistical Methods, 6th edn, (Iowa State University Press, Ames, IA), 502-503
35. Stoeckel, K., 1981. Pharmacokinetics of rocephin, a highly active new cephalosporin with an exceptionally long biological half life. Chemotherapy, 27, 42-46
36. Tegtmeier, C., Uttenthal, A.I., Triis N.F., Jensen, N.E. and Jensen, H.E., 1999. Pathological and microbiological studies on pneumonic lungs from Danish calves. Zentralblat für Veterinaer-medizin (B), 46, 693-700
37. Thornsberry, C., 1995. Trends in antimicrobial resistance among today's bacterial pathogens. Pharmacotherapy, 15(Supplement), 35-85
38. Van der Auwera, P. and Santella, P.J., 1991 Pharmacokinetics of cefepime a review. Journal of Antimicrobial Chemotherapy, 32, 103-115
39. Vuye, A. and Pijck., 1985. In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy, 27, 574-577
40. Yamaoka, K., Tanigawara, Y. and Nakagawa, T.T., 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175